Andrew Hantel

Sep 25, 2024 | healio.com | Josh Friedman |Matthew Shinkle |Mindy Valcarcel |Andrew Hantel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The AI revolution already has transformed delivery of cancer care. New algorithms rapidly identify patterns or abnormalities on imaging, improving diagnostic accuracy.

Sep 25, 2024 | healio.com | Josh Friedman |Matthew Shinkle |Mindy Valcarcel |Andrew Hantel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The AI revolution already has transformed delivery of cancer care. New algorithms rapidly identify patterns or abnormalities on imaging, improving diagnostic accuracy.

Aug 29, 2024 | onclive.com | Andrew Hantel

CommentaryVideoAugust 29, 2024Author(s):Andrew Hantel, MD, discusses eligibility criteria associated with racial and ethnic disparities in clinical trial participation in acute myeloid leukemia. Andrew Hantel, MD, physician, Dana-Farber Cancer Institute (DFCI); instructor, medicine, Harvard Medical School, discusses eligibility criteria that may perpetuate racial and ethnic disparities in clinical trial participation in patients with acute myeloid leukemia (AML).

Aug 15, 2024 | onclive.com | Andrew Hantel

CommentaryVideoAugust 15, 2024Author(s):Andrew Hantel, MD, discusses the environmental and health impacts of decentralizing cancer care in response to high emissions generated by health care. Andrew Hantel, MD, physician, Dana-Farber Cancer Institute (DFCI); instructor, medicine, Harvard Medical School, discusses findings from an evaluation of the environmental and health impacts of decentralizing cancer care in response to high emissions generated by United States health care.

Jun 18, 2024 | onclive.com | Andrew Hantel

CommentaryVideoJune 18, 2024Author(s):Andrew Hantel, MD, discusses the influence of race/ethnicity and socioeconomic status on the timeliness of first-line treatment in acute myeloid leukemia. Andrew Hantel, MD, physician, Dana-Farber Cancer Institute, instructor of medicine, Harvard Medical School, discusses the influence of race/ethnicity and socioeconomic status on the timeliness of first-line treatment initiation among patients with newly diagnosed acute myeloid leukemia (AML).